ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China flag China · Delayed Price · Currency is CNY
35.59
-1.01 (-2.76%)
Sep 4, 2026, 3:04 PM CST

SHE:300723 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,200515.38468.97422.52645.61,075
Short-Term Investments
---1--
Trading Asset Securities
45.33-4.7540.4472.1915.03
Cash & Short-Term Investments
1,246515.38473.72463.96717.781,090
Cash Growth
15.35%8.79%2.10%-35.36%-34.15%47.50%
Accounts Receivable
196.33242.2351.1451.38397.75243.39
Other Receivables
37.9340.111.2412.4812.427.16
Receivables
234.27282.31362.34463.86410.15270.55
Inventory
207.09215.91287.13346.44178.02114.97
Prepaid Expenses
-2.3822.681.02--
Other Current Assets
170.0385112.0284.58105.3788.02
Total Current Assets
1,8571,1011,2581,3601,4111,564
Property, Plant & Equipment
1,7221,7901,9281,7991,6861,043
Long-Term Investments
278.15525.57583.44633.55384.44408.01
Goodwill
0.260.260.2611.2811.2811.28
Other Intangible Assets
367.49390.19428.46446.79460.97460.42
Long-Term Deferred Tax Assets
153.83137.5129.1354.3447.3236.71
Long-Term Deferred Charges
89.0689.0959.3756.159.5358.53
Other Long-Term Assets
19.818.9817.3744.7837.08146.58
Total Assets
4,4884,0424,4044,4054,0983,728

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
81.6482.04107.84202.484.8340.65
Accrued Expenses
16.8749.0648.18126.2877.6573.15
Short-Term Debt
765.15520.081,000550550851.66
Current Portion of Long-Term Debt
61.36181.3460.29402.231.56
Current Portion of Leases
-1.7917.6326.3925.4923.06
Current Income Taxes Payable
8.93--37.8127.936.41
Current Unearned Revenue
11.8936.5738.848.37110.3620.99
Other Current Liabilities
303.89264.77459.5457.73330.37188.21
Total Current Liabilities
1,2501,1361,7321,4891,2091,206
Long-Term Debt
1,2251,368610160531.42270.45
Long-Term Leases
1.431.432.826.0358.5282.33
Long-Term Unearned Revenue
114.32108.9687.5483.3475.7684.45
Long-Term Deferred Tax Liabilities
17.5921.1435.4949.0158.0966.82
Total Liabilities
2,6082,6362,4681,8071,9331,710

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
451.69451.69451.69454.14288.08288.03
Additional Paid-In Capital
600.24592.8682.13814.15542.26570.59
Retained Earnings
949.22464.49802.291,4371,3091,075
Treasury Stock
-155.73-139.63-57.66-182.82-192.6-169
Comprehensive Income & Other
----104.82110.14
Total Common Equity
1,8451,3691,8782,5222,0511,874
Minority Interest
34.4737.3457.4375.83114.59144.07
Shareholders' Equity
1,8801,4071,9362,5982,1662,018
Total Liabilities & Equity
4,4884,0424,4044,4054,0983,728

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
2,0532,0731,691802.431,1681,229
Net Cash (Debt)
-807.27-1,558-1,217-338.46-449.87-139.01
Net Cash Growth
------
Net Cash Per Share
-1.79-3.45-2.69-0.75-1.04-0.33
Filing Date Shares Outstanding
451.72451.91451.65449.03424.45426.18
Total Common Shares Outstanding
451.72451.91451.65449.03424.45426.18
Working Capital
607.31-34.66-474.5-129.13202.47357.9
Book Value Per Share
4.093.034.165.624.834.40
Tangible Book Value
1,478978.91,4502,0641,5791,403
Tangible Book Value Per Share
3.272.173.214.603.723.29
Buildings
-1,2171,1801,039615.9575.71
Machinery
-1,093981.26820.5272.02244.21
Construction In Progress
-8.09141.94164.02904.37783.68